Incentives for Global Public Health: Patent Law and Access to Essential Medicines

Cambridge: Cambridge University Press, 2010

Posted: 9 Jul 2009 Last revised: 16 May 2018

See all articles by Thomas Pogge

Thomas Pogge

Yale Philosophy Department

Matthew Rimmer

Queensland University of Technology (QUT)

Kim Rubenstein

ANU College of Law

Date Written: 2010



Access to Essential Medicines: Public Health and International Law

Professor Thomas Pogge, Dr Matthew Rimmer, and Professor Kim Rubenstein Part I International Trade 1. TRIPS and Essential Medicines: Must One Size Fit All? Making the WTO Responsive to the Global Health Crisis

Professor Rochelle Cooper Dreyfuss, New York University 2. The TRIPS Waiver as a Recognition of Public Health Concerns in the WTO

Associate Professor Andrew Mitchell and Associate Professor Tania Voon, University of Melbourne 3. Public Law Challenges to the Regulation of Pharmaceutical Patents in the US Bilateral Free Trade Agreements

Dr Hitoshi Nasu, The Australian National University 4. Global Health and Development: Patents and Public Interest

Associate Professor Elizabeth Siew Kuan Ng, National University of Singapore

Part II Innovation 5. The Health Impact Fund: Boosting Innovation without Obstructing Free Access

Professor Thomas Pogge, Yale University and The Australian National University 6. The Health Impact Fund: A Critique

Dr Kathleen Liddell, University of Cambridge 7. A Prize System as a Partial Solution to the Health Crisis in the Developing World

Professor William W. Fisher and Talha Syed, Harvard Law School 8. Innovation and Insufficient Evidence: The Case for a WTO-WHO Agreement on Health Technology Safety and Cost-Effectiveness Evaluation

Associate Professor Thomas Faunce, The Australian National University Part III Intellectual Property 9. Opening the Dam: Patent Pools, Innovation, and Access to Essential Medicines

Professor Dianne Nicol and Dr Jane Nielsen, University of Tasmania 10. Open Source Drug Discovery: A Revolutionary Paradigm or a Utopian Model?

Dr Krishna Ravi Srinivas, Research Information System for Developing Countries (RIS), India 11. Accessing and Benefit Sharing Avian Influenza Viruses through the World Health Organisation: a CBD and TRIPS Compromise thanks to Indonesia’s Sovereignty Claim?

Dr Charles Lawson, Griffith University Faculty of Law and Associate Professor Barbara Hocking, Queensland University of Technology 12. The Lazarus Effect: The (RED) Campaign and Creative Capitalism

Dr Matthew Rimmer, The Australian National University Part IV Health-Care 13. Beyond TRIPS: The Role of Non-state Actors and Access to Essential Medicines

Professor Noah Benjamin Novogrodsky, University of Toronto 14. Securing Health Through Rights

Katharine Young, Harvard University

15. The Role of National laws in Reconciling Constitutional Right to Health with TRIPS Obligations: An Examination of the Glivec Patent Case in India

Dr Rajshree Chandra, Delhi University 16. Tipping Point: Thai Compulsory Licenses Redefine Essential Medicines Debate

Jonathan Burton-MacLeod, The Australian National University


Keywords: Access to Essential Medicines, International Trade Law, Innovation, Intellectual Property, Health-care, Public Law, International Law

Suggested Citation

Pogge, Thomas and Rimmer, Matthew and Rubenstein, Kim, Incentives for Global Public Health: Patent Law and Access to Essential Medicines (2010). Cambridge: Cambridge University Press, 2010, Available at SSRN:

Thomas Pogge

Yale Philosophy Department ( email )

P.O. Box 208206
New Haven, CT 06520-8206
United States
203-4322272 (Phone)


Matthew Rimmer (Contact Author)

Queensland University of Technology (QUT) ( email )

Level 4, C Block Gardens Point
2 George St
Brisbane, Queensland QLD 4000

Kim Rubenstein

ANU College of Law ( email )

Canberra, Australian Capital Territory 0200

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
PlumX Metrics